The FDA has removed the REMS requirement for Caprelsa (vandetanib), a kinase inhibitor for medullary thyroid cancer.

Studies evaluate levothyroxine’s impact on cardiovascular disease risk in midlife and older women and in adults with ...

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally ...

Mounjaro and Ozempic are two different drugs to manage type 2 diabetes and weight loss. Know all about their benefits and likely side effects.

Most patients with low-risk differentiated thyroid cancer do not require levothyroxine therapy at 3 years after hemithyroidectomy.

A diabetes and endocrine care practice has relocated to a new facility in Lakeway. The overview Bluebonnet Diabetes & ...

A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...

A new study jointly led by the School of Clinical Medicine at the LKS Faculty of Medicine, of the University of Hong Kong ...

Papillary thyroid cancer is the most common form of thyroid cancer, accounting for about 80% of all thyroid cancer diagnoses. It originates from the follicular cells in the thyroid gland, a ...

A recent announcement by the Food and Drug Administration about natural thyroid treatment has readers of this newspaper column up in arms. Nearly 5% of American adults have a thyroid gland that ...

Thyroid problems are often underdiagnosed because their symptoms mimic many common health issues, making misdiagnosis frequent. Regular check-ups and awareness of risk factors are essential for early ...

Dr. Amber Pinson-Hilkemeyer has recently joined the Mercy Endocrinology – Jefferson team, working alongside Dr. Shrenika ...